期刊
JOURNAL OF INFUSION NURSING
卷 31, 期 2, 页码 84-91出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.NAN.0000313655.65410.4e
关键词
-
类别
Intravenous catheter outcomes are a prominent topic for healthcare providers whose patients receive intravenous medications. There are thousands of products being marketed today claiming to improve catheter outcomes, thus improving overall patient outcomes and reducing provider costs associated with catheter infections and replacement. Catheter-related bloodstream infections (CR-BSIs) cost hospitals between $ 5000 and $ 34,000 per infection, and 12% to 25% of bloodstream infections are attributable to patient mortality. Products that claim to prevent CR-BSIs and subsequently reduce the number of bloodstream infections are a multimillion-dollar industry.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据